| Davis Kealanohea Kane, PHD | |
|
363 E 1200 S, Orem, UT 84058-6904 | |
| (801) 224-2313 | |
| Not Available |
| Full Name | Davis Kealanohea Kane |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 4 Years |
| Location | 363 E 1200 S, Orem, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386221760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Complete Evaluations Llc | 9335491588 | 4 |
News Archive
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
BHR Pharma, LLC announced today that the first patient has been enrolled in its SyNAPSe study, a global, Phase 3, pivotal trial to evaluate the safety and effectiveness of its intravenous progesterone infusion product (BHR-100) as a neuroprotective agent for treating severe (Glasgow Coma Scale scores of 4-8) traumatic brain injury patients.
Working together with researchers in the Université Paris-Sud in France and University Medical Centre Göttingen in Germany, ICREA Research Professor Toni Gabaldón and his team at the Centre for Genomic Regulation in Barcelona read the genetic code of 33 separate strains of the yeast Candida glabrata, the second most common cause of candidiasis.
The GAVI Alliance "is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline," Reuters reports in an article examining the group's efforts to vaccinate young women with Merck's Gardasil and GSK's Cervarix, "the world's only two approved shots designed to protect against the sexually transmitted human papillomavirus (HPV) that causes the vast majority of cervical cancer cases."
› Verified 9 days ago
| Entity Name | Complete Evaluations Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962994590 PECOS PAC ID: 9335491588 Enrollment ID: O20190115002795 |
News Archive
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
BHR Pharma, LLC announced today that the first patient has been enrolled in its SyNAPSe study, a global, Phase 3, pivotal trial to evaluate the safety and effectiveness of its intravenous progesterone infusion product (BHR-100) as a neuroprotective agent for treating severe (Glasgow Coma Scale scores of 4-8) traumatic brain injury patients.
Working together with researchers in the Université Paris-Sud in France and University Medical Centre Göttingen in Germany, ICREA Research Professor Toni Gabaldón and his team at the Centre for Genomic Regulation in Barcelona read the genetic code of 33 separate strains of the yeast Candida glabrata, the second most common cause of candidiasis.
The GAVI Alliance "is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline," Reuters reports in an article examining the group's efforts to vaccinate young women with Merck's Gardasil and GSK's Cervarix, "the world's only two approved shots designed to protect against the sexually transmitted human papillomavirus (HPV) that causes the vast majority of cervical cancer cases."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Davis Kealanohea Kane, PHD 95 S 100 E, Ste 300, Payson, UT 84651-2253 Ph: (801) 224-2313 | Davis Kealanohea Kane, PHD 363 E 1200 S, Orem, UT 84058-6904 Ph: (801) 224-2313 |
News Archive
The immunosuppressant sirolimus is an effective and safe steroid-sparing therapy for children and young adults with highly treatment-resistant autoimmune blood conditions, according to a study published online today in Blood, the Journal of the American Society of Hematology.
The Oregon Association of Hospitals and Health Systems lost an attempt to stop the implementation of a new law that will reduce their outpatient reimbursements by up to 50% starting January 1.
BHR Pharma, LLC announced today that the first patient has been enrolled in its SyNAPSe study, a global, Phase 3, pivotal trial to evaluate the safety and effectiveness of its intravenous progesterone infusion product (BHR-100) as a neuroprotective agent for treating severe (Glasgow Coma Scale scores of 4-8) traumatic brain injury patients.
Working together with researchers in the Université Paris-Sud in France and University Medical Centre Göttingen in Germany, ICREA Research Professor Toni Gabaldón and his team at the Centre for Genomic Regulation in Barcelona read the genetic code of 33 separate strains of the yeast Candida glabrata, the second most common cause of candidiasis.
The GAVI Alliance "is to help protect more than 180,000 girls in eight countries across Africa and Asia from cervical cancer by funding immunization projects with vaccines from Merck and GlaxoSmithKline," Reuters reports in an article examining the group's efforts to vaccinate young women with Merck's Gardasil and GSK's Cervarix, "the world's only two approved shots designed to protect against the sexually transmitted human papillomavirus (HPV) that causes the vast majority of cervical cancer cases."
› Verified 9 days ago
Eric Ghelfi, Psychologist Medicare: Medicare Enrolled Practice Location: 412 W 800 N, Orem, UT 84057 Phone: 801-235-7246 | |
Dr. A Lynn Scoresby, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 S State St, Suite #1, Orem, UT 84058 Phone: 801-225-9522 Fax: 801-225-9498 | |
Dr. Bradley Lynn Edgington, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 363 E 1200 S, Suite 201, Orem, UT 84058 Phone: 801-224-2313 Fax: 801-224-4475 | |
Geret Nolan Giles, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 703 S State St, Suite #1, Orem, UT 84058 Phone: 801-225-9522 Fax: 801-225-9498 | |
Heath Dean Granley, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1790 N State Street, Orem, UT 84057 Phone: 801-224-8255 Fax: 801-224-8301 | |
Dr. Melissa Hansen Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1790 N State Street, Center For Change, Orem, UT 84057 Phone: 801-224-8255 Fax: 801-224-8301 | |
Dr. Tyler Adam Money, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1453 N 1200 W, Orem, UT 84057 Phone: 801-734-4945 Fax: 801-734-4946 |